RXST Q3 2023 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M+143.1% YoY

Gross Profit

$14M44.8% margin

Operating Income

-$13M-40.8% margin

Net Income

-$12M-40.5% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+47.4%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$182M

Total Liabilities

$20M

Stockholders' Equity

$161M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$13M	+143.1%
Gross Profit	$14M	$5M	+156.4%
Operating Income	-$13M	-$16M	+21.6%
Net Income	-$12M	-$17M	+26.2%

Revenue Segments

L D D

$8M91%

Service Warranty Service Contracts And Accessories

$765,0009%